Weihong Cao

975 total citations
28 papers, 748 citations indexed

About

Weihong Cao is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Weihong Cao has authored 28 papers receiving a total of 748 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 11 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Weihong Cao's work include Cancer Immunotherapy and Biomarkers (4 papers), Immunotherapy and Immune Responses (3 papers) and Breast Cancer Treatment Studies (3 papers). Weihong Cao is often cited by papers focused on Cancer Immunotherapy and Biomarkers (4 papers), Immunotherapy and Immune Responses (3 papers) and Breast Cancer Treatment Studies (3 papers). Weihong Cao collaborates with scholars based in China, United States and Germany. Weihong Cao's co-authors include Xiaoyi Liu, Yiqun Zhang, Zhihao Wu, Lingzhi Wang, Zhengbiao Zhu, Mengmeng Yang, Hui Yang, Huijun Wei, Jie Feng and Haibo Wang and has published in prestigious journals such as Journal of Clinical Oncology, Oncogene and The FASEB Journal.

In The Last Decade

Weihong Cao

27 papers receiving 741 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weihong Cao China 12 395 285 245 162 78 28 748
Yuan Xiao Zhu United States 14 855 2.2× 250 0.9× 150 0.6× 134 0.8× 45 0.6× 26 1.1k
Chiqi Chen China 17 479 1.2× 142 0.5× 244 1.0× 180 1.1× 31 0.4× 34 792
Evelyn Aranda United States 11 412 1.0× 210 0.7× 126 0.5× 106 0.7× 55 0.7× 12 753
Nobuyuki Nishizawa Japan 20 437 1.1× 233 0.8× 169 0.7× 118 0.7× 151 1.9× 50 853
Rolanda Bailey United States 5 339 0.9× 226 0.8× 107 0.4× 131 0.8× 64 0.8× 7 686
Joanna Boncela Poland 19 363 0.9× 165 0.6× 209 0.9× 105 0.6× 96 1.2× 43 755
Rongfang Qiu China 21 732 1.9× 150 0.5× 269 1.1× 198 1.2× 205 2.6× 41 1.1k
Eva Løbner Lund Denmark 15 408 1.0× 235 0.8× 212 0.9× 72 0.4× 91 1.2× 45 753
Shanbao Cai United States 18 548 1.4× 153 0.5× 328 1.3× 88 0.5× 106 1.4× 35 864
Baoguo Li China 14 614 1.6× 232 0.8× 372 1.5× 217 1.3× 123 1.6× 32 1.0k

Countries citing papers authored by Weihong Cao

Since Specialization
Citations

This map shows the geographic impact of Weihong Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weihong Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weihong Cao more than expected).

Fields of papers citing papers by Weihong Cao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weihong Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weihong Cao. The network helps show where Weihong Cao may publish in the future.

Co-authorship network of co-authors of Weihong Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Weihong Cao. A scholar is included among the top collaborators of Weihong Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weihong Cao. Weihong Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Ma, Zhongliang, et al.. (2022). The role of DDX46 in breast cancer proliferation and invasiveness: A potential therapeutic target. Cell Biology International. 47(1). 283–291. 3 indexed citations
4.
Song, Hongming, Haibo Wang, Li Wu, et al.. (2021). Augmentation of antitumor function of tumor‐infiltrating lymphocytes against triple‐negative breast cancer by PD‐1 blockade. Cell Biology International. 46(2). 278–287. 5 indexed citations
5.
Lv, Meng, Weihong Cao, Xiaoyi Liu, et al.. (2020). Circular RNA 000554 represses epithelial‐mesenchymal transition in breast cancer by regulating microRNA‐182/ZFP36 axis. The FASEB Journal. 34(9). 11405–11420. 32 indexed citations
6.
Liu, Xiangping, et al.. (2019). PIM1 is responsible for IL-6-induced breast cancer cell EMT and stemness via c-myc activation. Breast Cancer. 26(5). 663–671. 55 indexed citations
7.
Jiang, Dandan, Yuhua Song, Weihong Cao, et al.. (2018). p53‑independent role of MYC mutant T58A in the proliferation and apoptosis of breast cancer cells. Oncology Letters. 17(1). 1071–1079. 7 indexed citations
8.
Liu, Xiaoyi, Jianxia Hu, Yueyun Li, et al.. (2018). Mesenchymal stem cells expressing interleukin-18 inhibit breast cancer in a mouse model. Oncology Letters. 15(5). 6265–6274. 34 indexed citations
9.
Feng, Jie, Hui Yang, Yiqun Zhang, et al.. (2017). Tumor cell-derived lactate induces TAZ-dependent upregulation of PD-L1 through GPR81 in human lung cancer cells. Oncogene. 36(42). 5829–5839. 304 indexed citations
10.
Nie, Gang, et al.. (2017). Breast cancer in "young" women: Age cutoff and clinicopathologic features.. Journal of Clinical Oncology. 35(15_suppl). e12019–e12019. 1 indexed citations
11.
Liu, Xiaoyi, Jianxia Hu, Funian Li, et al.. (2015). Mesenchymal stem cells expressing interleukin-18 suppress breast cancer cells in vitro. Experimental and Therapeutic Medicine. 9(4). 1192–1200. 40 indexed citations
12.
Ning, Bo, et al.. (2013). Good neurologic recovery after cardiac arrest using hypothermia through continuous renal replacement therapy. The American Journal of Emergency Medicine. 31(12). 1720.e1–1720.e3. 5 indexed citations
13.
Liu, Xiaoyi, Jianxia Hu, Weihong Cao, et al.. (2013). Effects of two different immunotherapies on triple negative breast cancer in animal model. Cellular Immunology. 284(1-2). 111–118. 8 indexed citations
14.
Wang, Haibo, Xiaojun Ji, Xiangping Liu, et al.. (2013). Lentivirus-mediated inhibition of USP39 suppresses the growth of breast cancer cells in vitro. Oncology Reports. 30(6). 2871–2877. 38 indexed citations
15.
Liu, Xiaoyi, Weihong Cao, Yu Wang, et al.. (2013). Efficacy of combined therapy of goserelin and letrozole on very young women with advanced breast cancer as first-line endocrine therapy. Endocrine Journal. 60(6). 819–828. 11 indexed citations
16.
Lv, Zhi‐Dong, Bin Kong, Jianguo Li, et al.. (2012). Transforming growth factor-β 1 enhances the invasiveness of breast cancer cells by inducing a Smad2-dependent epithelial-to-mesenchymal transition. Oncology Reports. 29(1). 219–225. 65 indexed citations
17.
Chen, Qingfeng, Zhengkun Wang, Kejun Zhang, et al.. (2011). Clusterin confers gmcitabine resistance in pancreatic cancer. World Journal of Surgical Oncology. 9(1). 59–59. 26 indexed citations
18.
Chai, Jiake, et al.. (2007). Characteristics of and strategies for patients with severe burn-blast combined injury. Chinese Medical Journal. 120(20). 1783–1787. 13 indexed citations
19.
Chai, Jiake, et al.. (2006). [Application of carbon fiber dressing on burn wounds].. PubMed. 44(15). 1047–9. 6 indexed citations
20.
Rupalla, Katrin, Weihong Cao, & Josef Krieglstein. (1995). Flupirtine protects neurons against excitotoxic or ischemic damage and inhibits the increase in cytosolic Ca2+ concentration. European Journal of Pharmacology. 294(2-3). 469–473. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuan Xiao Zhu Breakdown of academic impact, for papers by Chiqi Chen Breakdown of academic impact, for papers by Evelyn Aranda Breakdown of academic impact, for papers by Nobuyuki Nishizawa Breakdown of academic impact, for papers by Rolanda Bailey Breakdown of academic impact, for papers by Joanna Boncela Breakdown of academic impact, for papers by Rongfang Qiu Breakdown of academic impact, for papers by Eva Løbner Lund Breakdown of academic impact, for papers by Shanbao Cai Breakdown of academic impact, for papers by Baoguo Li
Rankless by CCL
2026